Back to Search
Start Over
109P Subsequent therapies after progressing to CDK4/6 inhibition (CDK4/6i) in hormone receptor positive/HER2 negative (HR+/HER2-) advanced breast cancer (ABC).
- Source :
-
Annals of Oncology . 2021 Supplement 2, Vol. 32, pS69-S70. 2p. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152686214
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.03.123